PRESS RELEASE published on 12/22/2025 at 18:00, 9 months 10 days ago ENOGIA: ENOGIA obtient un financement de 2 M€ auprès de Vatel Capital, pouvant être porté jusqu’à 3 M€ - Une opération qui sécurise le plan Turbo 2028 ENOGIA obtient un financement de 2 M€ auprès de Vatel Capital pour sécuriser le plan Turbo 2028. Opération avec obligations convertibles renforçant la visibilité financière Financement Obligations Convertibles ENOGIA Vatel Capital Turbo 2028
PRESS RELEASE published on 12/22/2025 at 18:00, 9 months 10 days ago Déclaration des transactions sur actions propres Klea Holding déclare les rachats d'actions propres conformément au règlement MAR, confirmant son expertise en acquisition et numérisation d'entreprises de divers secteurs Acquisition MAR Numérisation Rachats D'actions Klea Holding
PRESS RELEASE published on 12/22/2025 at 18:00, 9 months 10 days ago PERMANENT TRANSFER OF SAËL KUMBEDI TO WOLFSBURG Olympique Lyonnais announces permanent transfer of Saël Kumbedi to Wolfsburg for €6 million with potential €2 million bonuses and 10% sell-on clause. U21 defender played 62 matches and provided 5 assists Transfer Olympique Lyonnais Defender Saël Kumbedi Wolfsburg
PRESS RELEASE published on 12/22/2025 at 18:00, 9 months 10 days ago RÉSULTATS ANNUELS 2024/25 : UNE PERFORMANCE SOLIDE, DANS UN MARCHÉ EN REPLI Le Groupe Fountaine Pajot publie des résultats solides pour l'exercice 2024/25, préservant sa rentabilité et renforçant sa solidité financière. Des investissements ambitieux sont prévus pour les 50 ans de l'entreprise Résultats Financiers FOUNTAINE PAJOT Bateaux De Plaisance Investissements Ambitieux Nouvelle Génération
PRESS RELEASE published on 12/22/2025 at 18:00, 9 months 10 days ago BLCM - AGM 19.12.2025_Compte rendu de l'assemblée générale du 19 décembre 2025 BASTIDE LE CONFORT MEDICAL : Compte rendu de l'Assemblée Générale Mixte du 19 décembre 2025. Toutes les résolutions adoptées, documents accessibles en ligne Investisseurs Assemblée Générale Mixte Documents En Ligne BASTIDE LE CONFORT MEDICAL Résolutions Adoptées
PRESS RELEASE published on 12/22/2025 at 18:00, 9 months 10 days ago TRANSFERT DÉFINITIF DE SAËL KUMBEDI À WOLFSBURG L'Olympique Lyonnais finalise le transfert de Saël Kumbedi à Wolfsburg avec une option d'achat de 6M€ et des bonus potentiels. Le défenseur a joué 62 matches avec l'OL Transfert Olympique Lyonnais Défenseur Saël Kumbedi Wolfsburg
PRESS RELEASE published on 12/22/2025 at 18:00, 9 months 10 days ago Déclaration des transactions sur actions propres SCBSM déclare les rachats d'actions propres conformément au règlement Abus de marché. SCBSM est une foncière cotée sur Euronext Paris depuis 2006, avec un patrimoine immobilier majoritairement à Paris Euronext Paris Rachats D'actions Patrimoine Immobilier SCBSM SIIC
PRESS RELEASE published on 12/22/2025 at 17:58, 9 months 10 days ago Aramis Group - Declaration of transactions on own shares conducted from Dec 15 to Dec 19, 2025 Aramis Group declares recent purchases of own shares (FR0014003U94) conducted from December 15 to December 19, 2025, in compliance with regulations. More details on the transactions available on their website Transactions Sustainable Mobility Share Buybacks European Leader Aramis Group
PRESS RELEASE published on 12/22/2025 at 17:58, 9 months 10 days ago Aramis Group - Déclaration des transactions sur actions propres du 15.12 au 19.12.2025 Aramis Group déclare les achats d’actions propres du 15 au 19 décembre 2025 conformément aux réglementations. Pour plus d'informations, consultez le site internet d’Aramis Group Actions Propres Transactions Réglementation Investisseur Aramis Group
PRESS RELEASE published on 12/22/2025 at 17:57, 9 months 10 days ago AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040 AB Science's patent for masitinib in the treatment of sickle cell disease is formally granted in the United States, providing long-term protection until 2040. The biomarker Phase 2 in cooperation with AP-HP is fully funded Patent AB Science Masitinib Sickle Cell Disease Biomarker Phase 2
Published on 10/01/2026 at 23:05, 41 minutes ago Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 1 hour 46 minutes ago Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/01/2026 at 19:05, 4 hours 41 minutes ago PEL 90 Participating Interest Exchange with Chevron
Published on 10/01/2026 at 18:05, 5 hours 41 minutes ago Bocana Resources Corp. Provides a Corporate Update on Various Projects Currently Underway
Published on 10/01/2026 at 15:28, 8 hours 18 minutes ago Core Critical Metals Corp. Announces Shareholder Approval of Plan of Arrangement
Published on 10/01/2026 at 23:15, 31 minutes ago CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Published on 10/01/2026 at 20:45, 3 hours 1 minute ago Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 3 hours 16 minutes ago Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 18:55, 4 hours 51 minutes ago Ondo Finance Announces Expansion of Ondo Intelligent Portfolios to Seven With New Magnificent 7, AI and Targeted Portfolios
Published on 10/01/2026 at 19:00, 4 hours 46 minutes ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 19:00, 4 hours 46 minutes ago AMA CORP PLC réduit sa structure de coûts tout en préservant les fonctions clés de XpertEye
Published on 10/01/2026 at 18:40, 5 hours 6 minutes ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:40, 5 hours 6 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Septembre 2026
Published on 10/01/2026 at 18:07, 5 hours 39 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social